SOURCE: Equity Markets Inc

August 02, 2011 09:00 ET

Debt Ceiling & Resulting Market Influences - Research Report on ZOLL Medical Corporation and Boston Scientific Corporation

MACAU--(Marketwire - Aug 2, 2011) - Today, announced its research report highlighting ZOLL Medical Corporation (NASDAQ: ZOLL) and Boston Scientific Corporation (NYSE: BSX). Full content and research is available at

Top considerations within today's market lie with the U.S. Senate's ability to ratify a U.S. debt ceiling increase. Despite the US National Gross Domestic Product beginning to move beyond high-watermark, marking a significant shift away from recessionary pressures, continued momentum relies upon inking of the most recent tentative non-default agreement within senate before midnight tonight. The US Department of Commerce has confirmed growth within first quarter 2011, opening the strong possibility of companies within sub-sectors to experience organic revenue growth in the case of successful agreement.

No matter the outcome, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Fundamental positives in this area are provided by limited exposure to rising commodity costs. Although raw material cost increases will continue to pressure margins, well-positioned companies can leverage organic growth and general consolidation of product lines to sustain bottom-line growth. Market-wise investors are looking to build strong cash positions to take advantage of events in the coming weeks, carefully watching for value within equities boasting established pipelines and excellent growth prospects.

Equity Markets has reviewed ZOLL Medical Corporation for its focus on development and marketing of medical devices and software solutions which aid emergency care and save lives. The Company designs, manufactures and markets technologies that help advance the practice of resuscitation and temperature control therapies for the treatment of critical care patients. The full research report on ZOLL Medical Corporation (NASDAQ: ZOLL) is available here:

Equity Markets is covering Boston Scientific Corporation as a worldwide developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The full research report on Boston Scientific Corporation (NYSE: BSX) is available here:

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information